Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Benzinga Pro's 5 Stocks To Watch Today

ATYR, WMT, CHEK

Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user!

Walmart Inc (NYSE: WMT) was trading higher by nearly 2 percent Thursday morning in reaction to its first-quarter results. The retail behemoth reported a top-and-bottom-line beat while Walmart U.S. comps rose 2.1 percent and traffic rose 0.8 percent. Also, the company's e-commerce business saw its sales grow by 33 percent.

Check Cap Ltd (NASDAQ: CHEK) was trading higher by nearly 3 percent. The clinical stage medical diagnostics company reported its first-quarter results in which it lost $1.27 per share which was better than the $1.68 per share loss analysts were expecting.

aTyr Pharma Inc (NASDAQ: LIFE) was trading higher by more than 11 percent after falling 30 percent on Wednesday. The biotherapeutics company saw its stock fall Wednesday afternoon after announcing it will undergo a restructuring. On Thursday, the company announced a poster presentation at the American Thoracic Society (ATS) International Conference in which it will discuss the preclinical characterization of ATYR1923.

Loxo Oncology Inc (NASDAQ: LOXO) was trading higher by more than 12 percent. The biopharmaceutical company that focuses on medicines for patients with genetically defined cancers said its oral presentation of LOXO-292 was selected for the "Best of ASCO" program.

World Wrestling Entertainment, Inc. (NYSE: WWE) was trading higher by nearly 15 percent ahead of Thursday's open. The company's "Smackdown Live" may not be renewed at NBCUniversal network and the company's "Monday Night Raw" program could be worth three times its current value elsewhere, according to a report for The Hollywood Reporter.

Related Links:

22 Stocks Moving In Thursday's Pre-Market Session

A Peek Into The Markets: US Stock Futures Down Ahead Of JC Penney Earnings



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today